Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease?
Sorrentino
P
P
Tarantino
G
G
Conca
P
P
Perrella
A
A
D000368:Aged; D003327:Coronary Disease / Q000150:complications*; D017809:Fatal Outcome; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000188:drug therapy*; D015282:Octreotide / Q000009:adverse effects*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D005765:Gastrointestinal Agents; D014662:Vasoconstrictor Agents; D015282:Octreotide